pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·3h ago·1 min read
save

Trump proposes $90 monthly aid for seniors as stem cell therapies gain attention

Oct 6, 2026·read at STAT ↗Neutral

STAT's D.C. Diagnosis newsletter notes that stem cell treatments are being discussed as a possible next breakthrough in medicine, likening them to the rise of peptide therapies.

President Trump announced a plan to provide $90 a month to more than 20 million seniors to help cover Medicare premiums, a policy move that could affect many beneficiaries.

The article is presented as part of the STAT+ subscription service and highlights the intersection of health policy and emerging therapies.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Are stem cell treatments about to have their day?”

read at STAT ↗
421 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LILLYPFIZER
drugs
pirtobrutinib
topics
CLLOncologyPeptide TherapeuticVaccineVaccines

related stories

  • 3h agoSTAT+: AstraZeneca opens new Boston siteSTAT
  • 9h agoOpinion: Why the FDA should not approve an ineffective multicancer screening testSTAT
  • 1d agoSTAT+: Lilly’s Jaypirca approved as first-line CLL therapySTAT
  • 1h agoAdecto, Aviceda shut downBioSpace
  • 1d agoSTAT+: Utah plows ahead with more health AI pilots for prescriptions, women’s healthSTAT